SEC Form 4 · accession 0001127602-15-015426
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Apr 27, 2015
Accepted (ET)
Apr 28, 2015 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 27, 2015 | M | 15,322 | $53.42 | A | 15,562 | D | |
| Common StockF3 | Apr 27, 2015 | M | 2,592 | $52.65 | A | 18,154 | D | |
| Common StockF4 | Apr 27, 2015 | S | 200 | $170.83 | D | 17,954 | D | |
| Common StockF5 | Apr 27, 2015 | S | 292 | $172.0047 | D | 17,662 | D | |
| Common StockF6 | Apr 27, 2015 | S | 200 | $174.10 | D | 17,462 | D | |
| Common StockF7 | Apr 27, 2015 | S | 400 | $175.41 | D | 17,062 | D | |
| Common StockF8 | Apr 27, 2015 | S | 400 | $176.8285 | D | 16,662 | D | |
| Common StockF9 | Apr 27, 2015 | S | 400 | $177.9856 | D | 16,262 | D | |
| Common Stock | Apr 27, 2015 | S | 100 | $181.02 | D | 16,162 | D | |
| Common Stock | Apr 27, 2015 | S | 100 | $182.29 | D | 16,062 | D | |
| Common Stock | Apr 27, 2015 | S | 100 | $184.11 | D | 15,962 | D | |
| Common StockF10 | Apr 27, 2015 | S | 400 | $185.8925 | D | 15,562 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 594,387 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | $53.42 | Apr 27, 2015 | M | 15,322 | D | Dec 31, 2012 | Dec 31, 2022 | Common Stock | 15,322 | 76,610 | D |
| Stock Options | $52.65 | Apr 27, 2015 | M | 2,592 | D | Dec 31, 2009 | Dec 31, 2019 | Common Stock | 2,592 | 495,425 | D |
Explanation of responses
- F1Exercise of stock options pursuant to an "exercise and hold" transaction where none of the resulting shares were sold.
- F10This transaction was executed in multiple trades at prices ranging from $185.41 to $186.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F3Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F4This transaction was executed in multiple trades at prices ranging from $170.47 to $171.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $171.83 to $172.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $172.96 to $173.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $174.98 to $175.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $176.19 to $177.175. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $177.45 to $178.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.